Action FBIOP FORTRESS BIOTECH, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Fortress Biotech, Inc. Nasdaq

Actions

FBIOP

US34960Q2084

Marché Fermé - Nasdaq
Autres places de cotation
 21:58:22 07/06/2024 		Varia. 5j. Varia. 1 janv.
16,73 USD +1,70 % Graphique intraday de Fortress Biotech, Inc. +5,42 % +40,94 %
15/05 Fortress Biotech, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
14/05 Fortress Biotech annonce que le premier patient a été traité dans le cadre de l'étude de phase 2 du Triplex MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
Fortress Biotech: Q1 Earnings Snapshot
Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex
Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation
Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
Avenue Therapeutics Announces Reverse Stock Split
North American Morning Briefing : Powell Awaited -2-
Certain Warrants of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024.
Certain Options of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024.
Certain Common Stock of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024.
Fortress Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action FBIO
  4. Action FBIOP
  5. Actualités Fortress Biotech, Inc.
  6. Autres langues